
|Videos|September 28, 2022
Dr. Linehan on her experience and learning curve with HIFU
Author(s)Urology Times staff
“I feel like [HIFU] provided patients this intermediary treatment option…It was less invasive than radiation and surgery, but still provided cancer control, or at least for some patients delayed the time until they needed a more radical treatment,” says Jennifer A. Linehan, MD.
Advertisement
In this video, Jennifer A. Linehan, MD, discusses her clinical practice and experience with high-intensity focused ultrasound (HIFU) for patients with prostate cancer. Linehan is an associate professor of urology and urologic oncology at Saint John’s Cancer Institute in Santa Monica, California.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Dosing begins in trial of alpha radioligand therapy for mCRPC
2
High PHI scores are linked to increased odds of significant prostate cancer
3
Estradiol and ADT: Lessons from Lived Experience
4
Estradiol Patches in Prostate Cancer: Evidence and Impact
5




















